The cervical cancer vaccine is not mandatory. The cervical cancer vaccine is a blocker that specifically targets human papillomavirus, which can reduce the chance of infection of high-risk human papillomavirus and effectively prevent cervical lesions. Currently, there are many types of cervical cancer vaccines, such as 2-valent, 4-valent, 9-valent, etc. The higher the price, the more types of viruses the vaccine can cover. The cervical cancer vaccine is not yet widely available and is a voluntary option. The best time to get the vaccine is generally during adolescence, and its effects may not be as pronounced as in younger age groups if it is given to married women in their reproductive years. The cervical TCT and HPV tests should be performed before the cervical cancer vaccine is administered, and both should be negative before the vaccine can be used. If HPV infection is present, it should be administered only after the virus has turned negative. If the above two screenings are not abnormal in menopausal women, no further cervical cancer vaccination is recommended.